Bank of Montreal’s Theriva Biologics TOVX Stock Holding History

Bank of Montreal’s Portfolio TOVX Stock Details TOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2	Closed	–	–	4736
2018 Q4	$0	Hold	2	–	–	﹤0.01%	4856
2018 Q3	$1K	Hold	2	–	–	﹤0.01%	4601
2018 Q2	$5K	Buy	+2	New	+$4.59K	﹤0.01%	4136
2018 Q1	–	Hold	0	–	-$1K	–	4330
2017 Q4	–	Hold	0	–	–	–	4111

Other funds holding TOVX

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of Montreal's TOVX Position: Q1 2019 in Review

Bank of Montreal sold out of Theriva Biologics (TOVX) in Q1 2019, closing a stake of 2 shares.

Bank of Montreal first reported a position in TOVX in Q2 2018 and held it in 3 quarters. The position peaked at $5K in Q2 2018. 21 funds tracked by Wall St. Rank hold TOVX as of Q1 2019.

Bank of Montreal reported no remaining Theriva Biologics position as of Q1 2019 after selling out during the quarter.
Bank of Montreal sold 2 Theriva Biologics shares in Q1 2019.
Bank of Montreal first reported a position in Theriva Biologics in Q2 2018 and held it in 3 quarters.
Bank of Montreal's Theriva Biologics position peaked at $5K in Q2 2018.
21 funds tracked by Wall St. Rank held Theriva Biologics as of Q1 2019.

Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.